2023
DOI: 10.1002/adfm.202300474
|View full text |Cite
|
Sign up to set email alerts
|

Guanidine and Galactose Decorated Nanophotosensitizer with Oxygen Self‐Sufficient Capability for the Localized Ablation of Oral Biofilm

Abstract: Dental caries is a common disease caused by plaque biofilms, which are important pathogenic factors in many diseases. When hosts are overexposed to dietary sugars, pathogens such as Streptococcus mutans (S. mutans) and other cariogenic bacteria, metabolically assemble an extracellular matrix rich in exopolysaccharides to form a disease‐causing biofilm, in which the microenvironment is characterized by regional hypoxia, low pH, and nutritional deprivation. Current antimicrobials with inadequate penetration and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 61 publications
0
3
0
Order By: Relevance
“…Bacterial infections with drug-resistant bacteria pose a major challenge in treating the infection, and biofilm formation at the adhesion interface contributes significantly to drug resistance. , About 65% of microbial infections and 80% of chronic infections in humans are biofilms-associated according to the U.S. National Institutes of Health. A biofilm is a three-dimensional microbial community encapsulated in self-secreted extracellular polymeric substances (EPS) that are composed of polysaccharides, proteins, lipids, and extracellular DNA. ,, Bacteria in biofilms are 10–1000 times more resistant to antibiotics than plankton bacteria. The densely packed EPS prevents the bacteria from being attacked by the host immune system , and restricts the activity of antibacterial agents by limiting drug penetration, enhancing drug efflux and quorum sensing. , Recent antibiofilm strategies include disturbing the synthesis of EPS, interfering with metabolic activity, or directly killing persister cells. ,, The use of high-dose antibiotics is commonly recommended for treating biofilm-associated infections caused by bacteria with a low metabolic rate. However, overuse of antibiotics can result in the emergence of multiresistant bacteria, thereby rendering antibiotics ineffective and leading to recurrent infections. , To combat bacterial and biofilm-related infections, alternative antibacterial agents capable of penetrating deep biofilms are urgently needed. …”
Section: Introductionmentioning
confidence: 99%
“…Bacterial infections with drug-resistant bacteria pose a major challenge in treating the infection, and biofilm formation at the adhesion interface contributes significantly to drug resistance. , About 65% of microbial infections and 80% of chronic infections in humans are biofilms-associated according to the U.S. National Institutes of Health. A biofilm is a three-dimensional microbial community encapsulated in self-secreted extracellular polymeric substances (EPS) that are composed of polysaccharides, proteins, lipids, and extracellular DNA. ,, Bacteria in biofilms are 10–1000 times more resistant to antibiotics than plankton bacteria. The densely packed EPS prevents the bacteria from being attacked by the host immune system , and restricts the activity of antibacterial agents by limiting drug penetration, enhancing drug efflux and quorum sensing. , Recent antibiofilm strategies include disturbing the synthesis of EPS, interfering with metabolic activity, or directly killing persister cells. ,, The use of high-dose antibiotics is commonly recommended for treating biofilm-associated infections caused by bacteria with a low metabolic rate. However, overuse of antibiotics can result in the emergence of multiresistant bacteria, thereby rendering antibiotics ineffective and leading to recurrent infections. , To combat bacterial and biofilm-related infections, alternative antibacterial agents capable of penetrating deep biofilms are urgently needed. …”
Section: Introductionmentioning
confidence: 99%
“…3–5 In recent years, the widely explored nanoplatforms offered innovative approaches to combat bacterial infections. 6–11 Unlike traditional antibiotics which were only capable of directly inhibiting specific bacterial metabolic processes, nanoplatforms can assume multiple functions concurrently, thereby mitigating the emergence of bacterial resistance. 12–20 Furthermore, a range of stimulus-activated nanoplatforms have been designed, using ultrasound, 21 microwave, 22 light 23–27 and magnetic fields 28–31 as sources of stimulation.…”
Section: Introductionmentioning
confidence: 99%
“…However, the oral microbial ecosystem is complex, and periodontal infections can also be induced by anaerobic pathogenic bacteria and their associated biofilms, where conventional aPDT would be limited by the lack of oxygen. [16,17] In addition, aPDT is known to exhibit different damage against Grampositive and Gram-negative bacteria due to their different surface membrane structures. [18,19] Because of these issues, a highly efficient oxygen-free photosensitizer is needed for the application of aPDT-mediated treatment of periodontal disease.…”
Section: Introductionmentioning
confidence: 99%
“…[27,28] The presence of stubborn bacterial biofilms represents another potential barrier to the application of aPDT. [16,29] Abundant extracellular substances produced by the colonizing bacteria render biofilms relatively dense and impenetrable to drugs. Notably, it has been reported that nonenzymatic lectins are widespread in biofilms, and these lectins have a strong affinity for polysaccharides, which serve as important bacterial nutrients.…”
Section: Introductionmentioning
confidence: 99%